Aethlon Medical, Inc. (AEMD)
NCM · Healthcare · Medical Devices
$2.02
+6.32%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$4.8M
Shares Outstanding
2.4M
Exchange
NCM
Currency
USD
About Aethlon Medical, Inc.
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -1.8M | -1.5M | -2.1M | -1.9M |
| Net Income | -1.8M | -1.5M | -2.0M | -1.9M |
| Diluted EPS | $-0.85 | $-37.40 | $-2.45 | $nan |
Annual Financials
| Metric | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 574K | 0.00 | 0.00 | 0.00 |
| Operating Income | -11.9M | -12.6M | -9.3M | -7.3M |
| Net Income | -12.0M | -12.2M | -13.4M | -7.2M |
| Diluted EPS | $-47.20 | $-388.80 | $-85.77 | $-10.61 |